Urinary Nitrite/Nitrate Concentrations and Total Antioxidant Capacity in Patients with Chronic Hepatitis C in Therapy with Interferon and Ribavirin

REFERENCES

• Koziel MJ. Immunology of viral hepatitis. Am J Med 1996; 100: 98–109.
   PubMed Web of Science ®Google Scholar
• De Maria N, Colantoni A, Fagiuoli S et al. Association between reactive oxygen species and disease activity in chro-nic hepatitis C. Free Rad Biol Med 1996; 21: 291–295.
   Google Scholar
• Paradis V, Mathurin P, Kollinger M et al. In situ detec-tion of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J Clin Pathol 1997; 50: 401–406.
   Google Scholar
• Moraes CT, Shanske S, Tritschler HJ et al. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Gen 1991; 48: 492–501.
   Google Scholar
• Bredt DS, Snyder SH. Nitric oxide: a physiological mes-senger molecule. Annu Rev Biochem 1994; 63: 175–195.
   PubMed Web of Science ®Google Scholar
• Geller DA, Nussler AK, DiSilvio M. Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993; 90: 522–526.
   PubMed Web of Science ®Google Scholar
• Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumour necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic viral disease. Hepatology 1989; 10: 769–773.
   PubMed Web of Science ®Google Scholar
• Quiroga JA, Martin J, Pardo M., Carretio V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to inter-feron alpha. Dig Dis Sci 1994; 39: 2485–2496.
   Google Scholar
• Nguyen T, Brunson D, Crespi CL, Penman BW, Wishnok JS, Tannenbaum SR. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc Natl Acad Sci USA 1992; 89: 3030–3034.
   PubMed Web of Science ®Google Scholar
• Amaro MJ, Bartolomè J, Pardo M, Cotonat T, Lopez-Farre A, Carrel° V. Decreased nitric oxide production in chronic viral hepatitis B and C. J Med Virol 1997; 51: 326–331.
   PubMed Web of Science ®Google Scholar
• Moussa YI, Plevris JN, Hayes PC. Plasma nitrites/nitra-tes in HCV infection and hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2000; 12: 159–163.
   PubMed Web of Science ®Google Scholar
• Larrea E, Beloqui O, Mutioz-Navas MA, Civeira MP, Prieto J. Superoxide dismutase in patients with chronic hepati-tis C virus infection. Free Rad Biol Med 1998; 24: 1235–1241.
   PubMed Web of Science ®Google Scholar
• Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis. Hepatol 2000; 31: 241–246.
   PubMed Web of Science ®Google Scholar
• Consensus Panel. EASL international consensus confe-rence on hepatitis C. Paris, 26-28 February 1999.
   Google Scholar
• Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hyperten-sion. Lancet 1997; 349: 837–842.
   PubMed Web of Science ®Google Scholar
• Lussignoli S, Fraccaroli M, Andrioli G, Brocco G, Bellavite P. A microplate-based colorimetric assay of the total peroxyl radical trapping capability of human plasma. Anal Biochem 1999; 269: 38–44.
   PubMed Web of Science ®Google Scholar
• Guarini P, Stanzial AM, Olivieri O et al. Erythrocyte membrane lipids and serum selenium in post-viral and alcoho-lic cirrhosis. Clin Chim Acta 1998; 270: 139–150.
   Google Scholar
• Lake-Bakaar G, Sorbi D, Mazzoccoli V. Nitric oxide and chronic HCV and HIV infections. Dig Dis Sci 2001; 46: 1072–1076.
   PubMed Web of Science ®Google Scholar
• Moriyama A, Masumoto A, Nanri H et al. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. Am J Gastroenterol 1997; 92: 1520–1523
   Google Scholar
• Batista S, Bar F, Mongozzi G, Zanon E, Grosso M, Molino G. Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veins. J Hepatol 1997; 26: 75–80.
   PubMed Web of Science ®Google Scholar
• Ethem T, Guldal KM, Ali O, Nurcan M, Ender E, Hale AA. Increased serum nitrite and nitrate concentrations in chro-nic hepatitis. J Hepatol 1998; 29: 512–513.
   PubMed Web of Science ®Google Scholar
• Sakai T, Shiraki K, Sawai T, Ohmori S, Takase K, Nakano T. Increased plasma nitrate and nitrite concentrations in patients with hepatitis C virus infection. J Hepatol 2001; 34: 485–486.
   PubMed Web of Science ®Google Scholar
• Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacol Sci 2000; 21: 249–252.
   PubMed Web of Science ®Google Scholar
• Kroncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection. How, why, when, and where? Nitric Oxide Biol Chem 1997; 1: 107–120.
   PubMed Web of Science ®Google Scholar
• Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis alpha gene expression and response to inter-feron in chronic hepatitis C. Hepatol 1996; 23: 210–217.
   PubMed Web of Science ®Google Scholar
• Barbaro G, Di Lorenzo G, Asti A et al. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol 1999; 94: 2198-2205.
   Google Scholar
• Wayner DDM, Burton GW, Ingold KU, Barclay LRC, Locke SJ. The relative contributions of vitamin E, urate, ascor-bate and proteins to the total peroxyl radical-trapping antioxi-dant activity of human blood plasma. Biochim Biophys Acta 1987; 924: 408–419.
   PubMed Web of Science ®Google Scholar
• Maxwell SRJ, Thomason H, Sandler D et al. Antioxidant status in patients with uncomplicated insulin-dependent and non insulin-dependent diabetes mellitus. Eur J Clin Invest 1997; 27: 484–490.
   Google Scholar
• Aejmeleaus R, Ketela TM, Pirttila T, Hervonen A, Alho H. Unidentified antioxidant defences of human plasma in immobilized patients: a possible relation to basic metabolic rate. Free Rad Res 1997; 26: 335–341.
   PubMed Web of Science ®Google Scholar
• Hunt JV, Bottoms MA, Mitchinson MJ. Ascorbic acid oxidation: a potential cause of the elevated severity of athero-sclerosis in diabetes mellitus? FESS Lett 1992; 311: 161–164.
   PubMed Web of Science ®Google Scholar
• Holben DH, Smith AM. The diverse role of selenium within selenoproteins: a review. J Am Diet Assoc 1999; 99: 836–843.
   PubMed Web of Science ®Google Scholar
• Burk RF, Early DS, Hill KE, Palmer IS, Boeglin ME. Plasma selenium in patients with cirrhosis. Hepatol 1998; 27: 794–798.
   PubMed Web of Science ®Google Scholar
• Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ. Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol 1999; 150: 367–374.
   PubMed Web of Science ®Google Scholar
• Ryan M, Grayson L, Clarke DJ. The total antioxidant capacity of human serum measured using enhanced chemilu-minescence is almost completely accounted for by urate. Ann Clin Biochem 1997; 34: 688–689.
   PubMed Web of Science ®Google Scholar
• Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996; 9: 836–844.
   PubMed Web of Science ®Google Scholar
• Whiteman M, Halliwell B. Protection against peroxyni-trite-dependent tyrosine nitration and al-antiproteinase inacti-vation by ascorbic acid. A comparison with other biological antioxidants. Free Rad Res 1996; 25: 275–283.
   Google Scholar
• Mozaffarian N, Berman JW, Casadevall A. Immune complexes increase nitric oxide production by IFNy-stimulated murine macrophage-like J774.16 cells. J Leuko Biol 1995; 57: 657–661.
   PubMed Web of Science ®Google Scholar